Skip to main content
NVDA-1.21%AAPL+0.61%GOOGL+0.30%MSFT+0.10%AMZN+0.04%TSM+0.17%SPCX-4.21%META-0.61%AVGO+0.73%TSLA-0.85%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU-2.42%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.15%ASMLa-0.07%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.42%ABBV-2.42%1398.HK-0.92%CSCO-0.23%CVX+1.32%COST-0.50%ORCL+4.24%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%AP2d+0.20%PG-0.10%CAT-3.33%1816.HK+2.71%UNH-0.20%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.27%GE-0.33%PM-1.34%0939.HK-1.00%1288.HK-2.23%MS-1.77%NFLX-0.21%USDMXN+1.06%USDSEK+1.04%USDCHF+0.98%USDZAR+0.81%CADCHF+0.80%EURUSD-0.76%USDDKK+0.74%USDPLN+0.74%EURHKD-0.72%AUDCHF+0.66%GBPCHF+0.64%EURCNH-0.62%EURCAD-0.59%NZDUSD-0.57%CHFJPY-0.56%USDTHB+0.54%USDSGD+0.52%NZDMXN+0.44%USDNOK+0.44%NZDCAD-0.42%GBPTRY+0.41%EURAUD-0.41%USDJPY+0.40%AUDDKK+0.40%EURGBP-0.39%NZDCHF+0.38%CHFSEK+0.36%EURJPY-0.36%GBPUSD-0.35%PLNJPY-0.34%AUDUSD-0.33%GBPHKD+0.32%EURSEK+0.31%EURNOK-0.29%GBPZAR+0.28%GBPMXN-0.28%USDTRY+0.28%AUDNZD+0.27%CHFNOK-0.25%GBPNZD+0.22%CADJPY+0.21%EURSGD-0.21%EURCHF+0.20%NZDJPY-0.19%USDCAD+0.19%AUDSGD+0.18%USDILS+0.16%GBPCAD-0.15%CHFSGD-0.15%AUDCAD-0.14%EURNZD-0.14%SGDJPY-0.13%USDCNH+0.11%AUDNOK+0.10%EURCZK+0.09%NZDSGD-0.09%EURZAR+0.08%AUDJPY+0.07%GBPJPY+0.04%NOKJPY-0.04%USDCOP-0.04%EURPLN+0.01%USDHKD+0.01%GBPAUD-0.01%EURDKK+0.01%GBPSGD0.00%XAGUSD-4.20%GAGUSD-4.20%COFFEE+2.64%XPTUSD-2.13%GAUUSD-1.87%XAUUSD-1.87%COTTON+1.12%XNGUSD-1.07%SUGAR-0.71%HG1-0.57%UKOIL-0.54%USOIL+0.48%BTCUSD-0.87%ETHUSD+15.24%USDTUSD-0.01%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-0.65%DOGEUSD+11.12%XMRUSDT+0.81%LINKUSD+11.09%XLMUSD-2.53%BCHUSDT-0.77%LTCUSD+9.37%UNIUSD-4.87%SUIUSD-3.01%HBARUSDT-2.62%TONUSD+24.80%TAOUSDT-2.70%AAVEUSD-2.29%DOTUSDT-2.00%ICPUSDT-3.31%ONDOUSDT-3.93%WLDUSDT-4.62%ARBUSDT-4.63%JUPUSDT-4.67%ATOMUSDT-3.92%INJUSDT-3.74%STXUSDT-2.74%FETUSDT-3.36%PYTHUSDT+5.98%TIAUSDT-6.14%SEIUSDT-3.09%IMXUSDT-4.22%OPUSDT-9.29%GRTUSDT-3.69%WIFUSDT-3.22%IOTAUSDT-4.82%AXSUSDT-4.18%POLUSDT-4.59%FARTCOINUSDT-5.42%EOSUSDT+3.00%DYDXUSDT-5.46%GALAUSDT-5.44%ORDIUSDT-4.01%RONINUSDT-5.76%NOTUSDT-3.35%NVDA-1.21%AAPL+0.61%GOOGL+0.30%MSFT+0.10%AMZN+0.04%TSM+0.17%SPCX-4.21%META-0.61%AVGO+0.73%TSLA-0.85%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU-2.42%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.15%ASMLa-0.07%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.42%ABBV-2.42%1398.HK-0.92%CSCO-0.23%CVX+1.32%COST-0.50%ORCL+4.24%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%AP2d+0.20%PG-0.10%CAT-3.33%1816.HK+2.71%UNH-0.20%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.27%GE-0.33%PM-1.34%0939.HK-1.00%1288.HK-2.23%MS-1.77%NFLX-0.21%USDMXN+1.06%USDSEK+1.04%USDCHF+0.98%USDZAR+0.81%CADCHF+0.80%EURUSD-0.76%USDDKK+0.74%USDPLN+0.74%EURHKD-0.72%AUDCHF+0.66%GBPCHF+0.64%EURCNH-0.62%EURCAD-0.59%NZDUSD-0.57%CHFJPY-0.56%USDTHB+0.54%USDSGD+0.52%NZDMXN+0.44%USDNOK+0.44%NZDCAD-0.42%GBPTRY+0.41%EURAUD-0.41%USDJPY+0.40%AUDDKK+0.40%EURGBP-0.39%NZDCHF+0.38%CHFSEK+0.36%EURJPY-0.36%GBPUSD-0.35%PLNJPY-0.34%AUDUSD-0.33%GBPHKD+0.32%EURSEK+0.31%EURNOK-0.29%GBPZAR+0.28%GBPMXN-0.28%USDTRY+0.28%AUDNZD+0.27%CHFNOK-0.25%GBPNZD+0.22%CADJPY+0.21%EURSGD-0.21%EURCHF+0.20%NZDJPY-0.19%USDCAD+0.19%AUDSGD+0.18%USDILS+0.16%GBPCAD-0.15%CHFSGD-0.15%AUDCAD-0.14%EURNZD-0.14%SGDJPY-0.13%USDCNH+0.11%AUDNOK+0.10%EURCZK+0.09%NZDSGD-0.09%EURZAR+0.08%AUDJPY+0.07%GBPJPY+0.04%NOKJPY-0.04%USDCOP-0.04%EURPLN+0.01%USDHKD+0.01%GBPAUD-0.01%EURDKK+0.01%GBPSGD0.00%XAGUSD-4.20%GAGUSD-4.20%COFFEE+2.64%XPTUSD-2.13%GAUUSD-1.87%XAUUSD-1.87%COTTON+1.12%XNGUSD-1.07%SUGAR-0.71%HG1-0.57%UKOIL-0.54%USOIL+0.48%BTCUSD-0.87%ETHUSD+15.24%USDTUSD-0.01%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+1.88%ZECUSDT-0.65%DOGEUSD+11.12%XMRUSDT+0.81%LINKUSD+11.09%XLMUSD-2.53%BCHUSDT-0.77%LTCUSD+9.37%UNIUSD-4.87%SUIUSD-3.01%HBARUSDT-2.62%TONUSD+24.80%TAOUSDT-2.70%AAVEUSD-2.29%DOTUSDT-2.00%ICPUSDT-3.31%ONDOUSDT-3.93%WLDUSDT-4.62%ARBUSDT-4.63%JUPUSDT-4.67%ATOMUSDT-3.92%INJUSDT-3.74%STXUSDT-2.74%FETUSDT-3.36%PYTHUSDT+5.98%TIAUSDT-6.14%SEIUSDT-3.09%IMXUSDT-4.22%OPUSDT-9.29%GRTUSDT-3.69%WIFUSDT-3.22%IOTAUSDT-4.82%AXSUSDT-4.18%POLUSDT-4.59%FARTCOINUSDT-5.42%EOSUSDT+3.00%DYDXUSDT-5.46%GALAUSDT-5.44%ORDIUSDT-4.01%RONINUSDT-5.76%NOTUSDT-3.35%
RE

Revvity, Inc. (RVTY)

NYSE • Healthcare

$155.08
-$0.53 (-0.3%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$156.44
Day Range$153.1 - $157.27
Avg. Volume (3M)2.2M
Market Cap$17.3B
P/E Ratio73.8
52 Week Range
$81.22$166.25
Next EarningsIn 20 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$729.6M100%
Gross Profitminus cost of goods$416.8M57%
Operating Incomeminus R&D and overhead$89.3M12%
Net Incomeminus taxes and the rest$51.8M7%

In plain terms: out of every $100 in revenue, Revvity, Inc. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.9B
Net Income (TTM)
$237.5M
EPS (TTM)
$2.1
ROA (TTM)
1.97%
Current Ratio
1.8
Dividend Yield
0.062%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+8.3%Q1 2026$1.7
+3.9%Q2 2026$1.06
+16.5%Q3 2026$1.41
Next

Nov 3

in 20 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +16.5%

Revvity beat on adjusted EPS in the second fiscal quarter of 2026, reporting on Aug. 4 based on preliminary results, as adjusted EPS of $1.41 topped the $1.21 estimate by 16.5%. Revenue rose about 1% to roughly $729.7 million, with operating income at about $89.3 million, operating margin near 12%, and gross margin around 57%; net income came to about $51.8 million, down about 6% from about $55.2 million a year earlier. The company generated operating cash flow of about $195.6 million, repurchased $16.0 million of stock, and paid $7.8 million in dividends. Consensus for the next period calls for EPS of $1.30.

Next report — what to expect

Revvity, Inc. (RVTY) reports on October 26, 2026. Wall Street is expecting consensus EPS of $1.28 on consensus revenue of $694.4 million. For trailing context, revenue grew +1.3% year over year last quarter. Revvity has beaten EPS in 8 of 8 most recent quarters, making EPS versus expectations a key watch item.

View full earnings history

About Revvity, Inc.

Revvity, Inc. (NYSE: RVTY) develops diagnostic and life sciences tools, software, and services for healthcare and research markets worldwide. The company, which operates in medical diagnostics and research, generated $2.9 billion of revenue in FY2025. It sells across discovery, analytical, and testing workflows rather than through a single product line.

Name
Revvity, Inc.
CEO
Prahlad R. Singh
Industry
Healthcare
Year Founded
1937
Employees
11,000

Today's Snapshot

AI-generated

RVTY closed slightly lower at 155.08. JPMorgan, an investment bank, raised its estimate for Revvity’s share value to $155 from $110.

Trading Volume

Below 10d avg (2.0M)

1.3M

vs S&P 500 Today

Moderate Underperformance

-0.32%

Updated: October 14, 2026 at 12:17 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
RVTY at 155.08 exhibits a robust technical backdrop with a strong trend (ADX about 42.6) and healthy momentum—RSI in the mid‑60s and a sizable MACD—while the price sits comfortably above short, medium and 200‑day moving averages, signaling multi‑timeframe strength. Volume supports the advance as OBV is positive, and volatility is reasonable with ATR around $5.44, while pivots are close to the current price and presently neutral. Collectively the indicators point to broad underlying strength. Technical takeaway: Strong Buy—trend and volume are aligned in favor of buyers.
All signals
  • EMA (5 indicators)$113.54 - $152.98
    Buy
  • RSI (14)66.12
    Neutral
  • Stochastic %K (14, 3, 3)55.85
    Neutral
  • MACD Level (12, 26)6.28
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.